CALPW Caliper Life Sciences Inc featured news, full reports, and detailed charts
Caliper Life Sciences Inc (CALPW) Wrap Up:
Caliper Life Sciences, Inc. develops and sells innovative and enabling products and services to the life sciences research community, a customer base that includes pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions. We believe our integrated systems, consisting of instruments, software and reagents, our laboratory automation tools and our assay and discovery services enable researchers to better understand the basis for disease and more effectively discover safe and effective drugs. Our strategy is to transform drug discovery and development by offering technologies and services that ultimately enhance the ability to predict the effects that new drug candidates will have on humans. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f14%2f0001047469-08-002786.html#FIS_BUSINESS"Caliper Life Sciences Inc (CALPW:NASDAQ)
Snapshot of Caliper Life Sciences Inc (CALPW)
|
OPEN
--
|
PREVIOUS CLOSE
$0.11
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
07/7/09 - $0.35
|
52 WEEK LOW
02/24/09 - $0.01
|
|
|
MARKET CAP
0.0
|
AVERAGE VOLUME 3 mo
556.0
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
0.0
|
|
|
CALPW Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
CALPW Top Compensated Officers
Executives, Board Directors
Key developments for Caliper Life Sciences Inc (CALPW)
Caliper Life Sciences, Inc. announced the availability of two new products that expand the LabChip GX product line: a GLP/GMP-compliant version of the operating software for the LabChip GX instrument that is amenable to manufacturing QC environments and a new protein assay with higher, silver stain levels of sensitivity. The LabChip GX platform has been broadly adopted by biopharmaceutical companies and academic institutions for protein therapeutics, vaccines, and nucleic acid applications. LabChip GX platform provides unique speed, throughput, cost, and data quality advantages for biologicals and has just begun to be adopted by vaccine producers. The LabChip GX is ideally suited for high throughput characterization of subunit and virus-like particle vaccines, which have emerging uses for the H1N1 influenza, or swine flu, and similar viruses, and the LabChip EZ Reader(®) platform is being used to identify small molecule antiviral drugs that inhibit viral proteases.
Caliper Life Sciences Inc. announced that they will report Q3, 2009 results on November 09, 2009.
Caliper Life Sciences, Inc., Q3 2009 Earnings Call, Nov-09-2009
CALPW Competitors
| Company | Last | Change |
| CombinatoRx Inc | $1.07 USD | +0.19 |
| Cybio | €1.02 EUR | 0.00 |
| Sequenom Inc | $3.13 USD | +0.03 |
| SeraCare Life Sciences Inc | $3.63 USD | +0.68 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | CALPW | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 1.0x |
|
| Price/Book | 2.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.7x |
|
|
CALPW |
||
CALPW transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||